Showing results (231-240 of 289) with videos related to
Sort By:
Pageof 29
European Journal of Internal Medicine|February 19, 2026
Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AFGeorge Ntaios, Andreas Goette, Michael G Palazzolo, et al.Journal of Cellular and Molecular Medicine|August 23, 2018
BDNF: mRNA expression in urine cells of patients with chronic kidney disease and its role in kidney functionNicole Endlich, Tim Lange, Jana Kuhn, et al.European Heart Journal. Cardiovascular Pharmacotherapy|March 27, 2025
Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapyDan Atar, Christophe Vandenbriele, Stefan Agewall, et al.BMC Health Services Research|November 27, 2024
An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare payer perspectiveMalte Kuniss, Lucy Hillcoat, Joe Moss, et al.Circulation|August 15, 2022
Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity BurdenAndreas Rillig, Katrin Borof, Günter Breithardt, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 10, 2021
Cost-Effectiveness Analyses of an Absorbable Antibacterial Envelope for Use in Patients at Increased Risk of Cardiac Implantable Electronic Device Infection in Germany, Italy, and EnglandGiuseppe Boriani, Charles Kennergren, Khaldoun G Tarakji, et al.European Journal of Heart Failure|January 18, 2019
Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fractionStefan D Anker, Martin Borggrefe, Hans Neuser, et al.Lancet (London, England)|September 8, 2019
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trialPascal Vranckx, Marco Valgimigli, Lars Eckardt, et al.Circulation|November 12, 2023
Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA TrialsWilliam F McIntyre, Alexander P Benz, Nina Becher, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 8, 2025
Prevalence and severity of atrial cardiomyopathy in patients with recently diagnosed atrial fibrillation and stroke risk factors and its association with early rhythm control: a secondary analysis of EAST-AFNET 4Andreas Goette, Marc D Lemoine, Katrin Borof, et al.Pageof 29